The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
Abdelmalek, Manal F., Charles, Edgar D., Sanyal, Arun J., Harrison, Stephen A., Neuschwander-Tetri, Brent A., Goodman, Zachary, Ehman, Richard A., Karsdal, Morten, Nakajima, Atsushi, Du, Shuyan, Tirucherai, Giridhar S., Klinger, George H., Mora, Johanna, Yamaguchi, Masayuki, Shevell, Diane E., Loomba, Rohit
Published in Contemporary clinical trials (01.05.2021)
Published in Contemporary clinical trials (01.05.2021)
Get full text
Journal Article